The demarcation between drugs and medical devices

Latest Perspectives

• 2019

  Mayer Brown's Capabilities in the UK and Europe for Japanese Businesses

• January 31

  2019

  China's SAMR Fines Hunan Er-Kang and Henan Jiushi CNY 10 million for Unfair Pricing of Chlorpheniramine API

• January 24

  2019

  Europe—New Regulation (EU) 2019/5 Extends Financial Penalties to Entities Beyond the Marketing Authorization Holder and Updates the Legal Framework for Medicinal Products for Human Use